New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

Bristol Myers Squibb said it will enroll more patients in a key Phase 3 trial studying its drug Cobenfy in psychosis associated with Alzheimer’s disease, after the company found “irregularities due to ...

Boomers don’t always talk about the lessons life taught them, but you can see the wisdom in the way they move through the ...

Here are eight daily rituals emotionally resilient people tend to rely on when life gets tough. Ever notice how chaotic ...

Maintaining lean muscle is a powerful way to promote healthy aging, influencing everything from mobility and independence to ...

Using a single-group pre-post design, this study examined the short-term effects of a mesocycle focused on plyometrics ...